Riskpilot← Back to searchSign inGet full accessStora Höga Läkarhus AB
ABActiveOrg 5593207201Selins Väg 7General medical practice activities · NACE 8621Est. 202143 employees
Revenue 2025
SEK 45,4M
+35% vs 2024
EBITDA margin
5.1%
+31% vs 2024
Equity ratio
32.6%
Financial strength
Net profit 2025
SEK 760K
-40% vs 2024
| Revenue | SEK 45,4M | +35% |
| EBITDA | SEK 2,3M | +31% |
| Net profit | SEK 760K | -40% |
| Total assets | SEK 11,5M | +16% |
| Equity | SEK 3,8M | +25% |
| Employees | 43 | — |
Legal name
Stora Höga Läkarhus AB
Org number
5593207201
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 juni 2021
Share capital
SEK 25 000
Employees
43 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva vårdcentral samt därmed förenlig verksamhet.
Address
Selins Väg 7
Email
karin.svensson@lakarhusenivast.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 799 | 22 290 | 33 682 | 45 355 |
| Staff expenses | — | −2 535 | −14 418 | −22 203 | −28 241 |
| EBITDA | −14 | −4 553 | −572 | 1 760 | 2 306 |
| Depreciation & amort. | −0 | −27 | −132 | −137 | −139 |
| EBIT | −14 | −4 580 | −704 | 1 623 | 2 167 |
| Net financials | — | 0 | 2 | −11 | −1 |
| Profit before tax | −14 | 2 157 | 18 | 1 638 | 1 024 |
| Tax | −0 | −445 | −17 | −364 | −264 |
| Net profit | −14 | 1 712 | 1 | 1 274 | 760 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 525 | 7 008 | 7 506 | 9 931 | 11 534 |
| Equity | 511 | 2 223 | 2 224 | 2 998 | 3 758 |
| Long-term debt | 0 | — | — | — | 2 000 |
| Short-term debt | 14 | 4 622 | 5 118 | 6 795 | 5 246 |
| Total debt | 14 | 4 622 | 5 118 | 6 795 | 7 246 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20212025
Equity ratio
32.6%
This company
38.2%
Market median
+15% vs market
20212025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20212025
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20212025
Debt / equity
2.07×
This company
0.62×
Market median
-234% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RM Chief Executive Officer | Chief Executive Officer | 2025 |
EG Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AM Chief Auditor | Chief Auditor | 2025 – 2025 |
BH Audit | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPEKAEL AB
Stora Höga Läkarhus AB Board members of Stora Höga Läkarhus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Mikaela Hedin Göran | Chief Auditor | 0 companies |
| Rolf Mikael Spetz | Chief Executive Officer | 0 companies |
| Bo Helge Eugén Östh | Audit | 0 companies |
| Erik Gunnar Hansson | Chief Auditor | 0 companies |
| Karin Therese Svensson Stolt | Deputy Board Member | 0 companies |